Publicaciones en las que colabora con Emilio Álvarez Fernández (14)

2016

  1. Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 8, pp. 1444-1452

2015

  1. Human cytomegalovirus and Epstein-Barr virus infection impact on 18F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 2, pp. 186-196

2014

  1. Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: No increased risk associated with distal margin

    Clinical and Translational Oncology, Vol. 16, Núm. 6, pp. 573-580

  2. Post-chemoradiation intraoperative electron-beam radiation therapy boost in resected locally advanced rectal cancer: Long-term results focused on topographic pattern of locoregional relapse

    Radiotherapy and Oncology, Vol. 112, Núm. 1, pp. 52-58

  3. Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer: Long-term outcome analysis

    Strahlentherapie und Onkologie, Vol. 190, Núm. 2, pp. 149-157

2013

  1. 18F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: A prospective validation of long-term outcomes

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 5, pp. 657-667

  2. Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 11, pp. 1635-1644

  3. Intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma: Topography of locoregional recurrences and long-term outcomes

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 443-449

2012

  1. Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: Long-term outcome

    European Journal of Surgical Oncology, Vol. 38, Núm. 10, pp. 955-961

2010

  1. 18F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics

    Radiotherapy and Oncology, Vol. 97, Núm. 2, pp. 212-216

2006

  1. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

    Annals of Oncology, Vol. 17, Núm. 7, pp. 1103-1110

  2. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation

    International Journal of Radiation Oncology Biology Physics, Vol. 64, Núm. 4, pp. 1122-1128

2004

  1. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

    International Journal of Radiation Oncology Biology Physics

2001

  1. Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-Fluorouracil vs. Tegafur

    International Journal of Radiation Oncology Biology Physics, Vol. 51, Núm. 5, pp. 1264-1270